The enrichment of HRDEGs in the TNF signaling pathway suggests that these genes could be contributing to the heightened inflammatory state in IBD, supporting their possible diagnostic biomarkers or therapeutic targets. This evidence concerns the gene TNF and inflammatory bowel disease.